Drug Candidate for Chronic Cough Rejected by FDA Panel

(MedPage Today) -- FDA advisors told the agency that the current evidence does not support approval of gefapixant for chronic cough, a condition where no approved therapy exists. On Friday, members of the Pulmonary-Allergy Drugs Advisory Committee...
Source: MedPage Today Allergy - Category: Allergy & Immunology Source Type: news